AU2001278951A1 - Compounds and methods - Google Patents

Compounds and methods

Info

Publication number
AU2001278951A1
AU2001278951A1 AU2001278951A AU7895101A AU2001278951A1 AU 2001278951 A1 AU2001278951 A1 AU 2001278951A1 AU 2001278951 A AU2001278951 A AU 2001278951A AU 7895101 A AU7895101 A AU 7895101A AU 2001278951 A1 AU2001278951 A1 AU 2001278951A1
Authority
AU
Australia
Prior art keywords
compounds
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278951A
Inventor
Joseph P. Marino Jr.
Scott K. Thompson
Daniel F. Veber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2001278951A1 publication Critical patent/AU2001278951A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
AU2001278951A 2000-07-19 2001-07-19 Compounds and methods Abandoned AU2001278951A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21931000P 2000-07-19 2000-07-19
US60219310 2000-07-19
PCT/US2001/022669 WO2002005804A1 (en) 2000-07-19 2001-07-19 Compounds and methods

Publications (1)

Publication Number Publication Date
AU2001278951A1 true AU2001278951A1 (en) 2002-01-30

Family

ID=22818754

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278951A Abandoned AU2001278951A1 (en) 2000-07-19 2001-07-19 Compounds and methods

Country Status (2)

Country Link
AU (1) AU2001278951A1 (en)
WO (1) WO2002005804A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003510359A (en) 1999-10-01 2003-03-18 スミスクライン・ビーチャム・コーポレイション Compounds and methods
US7618948B2 (en) 2002-11-26 2009-11-17 Medtronic, Inc. Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
US7994149B2 (en) 2003-02-03 2011-08-09 Medtronic, Inc. Method for treatment of Huntington's disease through intracranial delivery of sirna
US20050239836A1 (en) 2004-03-09 2005-10-27 Varghese John Substituted hydroxyethylamine aspartyl protease inhibitors
US9133517B2 (en) 2005-06-28 2015-09-15 Medtronics, Inc. Methods and sequences to preferentially suppress expression of mutated huntingtin
WO2007047305A1 (en) 2005-10-12 2007-04-26 Elan Pharmaceuticals, Inc. Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
US9273356B2 (en) 2006-05-24 2016-03-01 Medtronic, Inc. Methods and kits for linking polymorphic sequences to expanded repeat mutations
US9375440B2 (en) 2006-11-03 2016-06-28 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056372A1 (en) * 1997-06-09 1998-12-17 Massachusetts Institute Of Technology TYPE 2 METHIONINE AMINOPEPTIDASE (MetAP2) INHIBITORS AND USES THEROF
US6242494B1 (en) * 1998-05-01 2001-06-05 Abbott Laboratories Substituted β-amino acid inhibitors of methionine aminopeptidase-2

Also Published As

Publication number Publication date
WO2002005804A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2001262847A1 (en) Language-understanding
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2001243394A1 (en) Compounds and methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001258924A1 (en) Microsatellite-aflp
AU2002359694A1 (en) Compounds and methods
AUPQ872300A0 (en) Compounds and methods
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001278951A1 (en) Compounds and methods
AU2001281921A1 (en) Bdellosomes
AU2001266176A1 (en) Methods
AU2001246864A1 (en) Hypotensors
AU4432001A (en) Trityl-type compounds and their use
AU2002235277A1 (en) Compounds and methods
AU2002256556A1 (en) Sea-trosy and related methods
AU2001250536A1 (en) Methods
AU2001284173A1 (en) Calycins